Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest PEGylation Stories

2013-05-31 08:24:26

NES-ZIONA, Israel, May 31, 2013 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE MKT: PBTH), a clinical stage company developing next generation biobetter therapeutic proteins, today announced that company management will give a corporate presentation at the Jefferies 2013 Global Healthcare Conference, being held at the Grand Hyatt Hotel in New York City. The presentation is scheduled for June 4, 2013 at 4:30 pm ET. A live webcast of the company's presentation will be available at the Investors...

2013-05-30 16:26:51

SAN FRANCISCO, May 30, 2013 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the upcoming 2013 Jefferies Global Healthcare Conference in New York at the Grand Hyatt Hotel on Tuesday, June 4, 2013 at 9:00 a.m. Eastern time. The presentation will be accessible via a Webcast through a link posted in the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com. This...

2013-05-16 20:22:52

SAN FRANCISCO, May 16, 2013 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the upcoming 2013 UBS Global Healthcare Conference in New York at the Sheraton New York Hotel on Tuesday, May 21, 2013 at 10:00 a.m. Eastern time. The presentation will be accessible via a Webcast through a link posted in the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com. This Webcast will...

2013-05-02 16:30:49

SAN FRANCISCO, May 2, 2013 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter ended March 31, 2013 on Thursday, May 9, 2013, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). The press release and a live audio-only Webcast of the conference call can be...

2013-04-17 12:25:20

Polaris Scientific Colleagues from Several University Cancer Centers Present Data at 2013 AACR Meeting in Washington, DC SAN DIEGO, April 17, 2013 /PRNewswire/ -- Scientists from academic institutions reported at the 2013 annual American Association for Cancer Research meeting, results from preclinical studies which showed that certain bladder cancers and mesotheliomas have metabolic changes and are more likely to respond to treatment with ADI-PEG 20 (pegylated arginine deiminase) if...

2013-03-28 16:24:33

ReportsnReports.com offers 2013 market research reports on polymer biomaterials and protein engineering industry products like monoclonal antibodies, insulin analog and modified EPO. DALLAS, March 28, 2013 /PRNewswire-iReach/ -- Market Research on Biomaterials and Protein Engineering Industry Products with Technology and Applications (Photo: http://photos.prnewswire.com/prnh/20130328/CG85250) The global biomaterials market is poised to grow at a CAGR of 15% from 2012 to 2017 to...

2013-03-20 08:25:34

DALLAS, March 20, 2013 /PRNewswire/ -- The report "Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017", analyses the global protein engineering market by products, technology, applications, and geography with five-year revenue forecasts. It also identifies the factors driving and restraining the...

2013-02-26 08:29:37

BRIDGEWATER, N.J., Feb. 26, 2013 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that the Company's fourth quarter and year-end 2012 financial results will be released prior to the market open on Tuesday, March 19, 2013. Savient's executive management will host a conference call beginning at 9:00 a.m. Eastern Time on March 19, 2013, to discuss these results and to answer questions. To participate by telephone, please dial 866-393-1565 (Domestic) or 253-237-1151...

2013-02-13 08:28:03

SAN FRANCISCO, Feb. 13, 2013 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2012 on Thursday, February 28, 2013, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review these results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). The press release and a live audio-only Webcast of the conference...

2013-01-08 08:30:53

BRIDGEWATER, N.J., Jan. 8, 2013 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that David Meeker, M.D., President and Chief Executive Officer of Genzyme, a Sanofi Company, has been elected to Savient's Board of Directors, effective January 7, 2013. In addition, Savient announced the resignation from the Company's Board of William F. Owen, Jr., M.D., who is relocating to Qatar to serve as Chief Executive Officer of the Sidra Medical and Research Center, a...